Community pharmacy confronts an Amazon-size headache
For the pharmaceutical industry, and particularly drug store retail chains like CVS Pharmacy and Walgreens, Amazon.com is about to become a headache that not even the strongest pain meds can cure.
Opinion
Preserving the impact of biopharmaceutical innovation
Health care economists, health system leaders and policy makers have been talking seriously about measuring and paying for value in health care for more than a decade.
How to navigate disruption in retail pharmacy
NEW YORK – Few industries have escaped the radical shifting of landscape that has been the collateral damage of digitization.
PillPack buy shows Amazon’s outcome-first approach
A year after announcing it was acquiring Whole Foods Market, Amazon.com made a splash again, this time in the health care sector.
Using drug spend, utilization data to improve outcomes
Thanks to the ever-growing applications of data analytics technology, chain drug stores have a unique opportunity to create benefits ranging from improved member outcomes to lowered spending.
Report takes close look at reverse distribution
Reverse distribution of pharmaceutical products accounts for 3.5% to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in value, according to a new report from the Healthcare Distribution Alliance (HDA) Research Foundation.
In face of Amazon, Rx needs to stay course
Amazon’s long anticipated, much ballyhooed entry into the retail pharmacy sector has finally taken place.
CVS-Aetna: an answer to a broken system
All indications are that CVS Health’s $77 billion acquisition of Aetna is on track to be finalized by the end of the year.
Opportunities for brick-and-mortar retailers
With e-commerce capturing a growing slice of the retail pie, the future of the physical store becomes a more urgent question.
Trump takes a shot at lowering Rx prices
President Trump has unveiled the administration’s much anticipated plan to reduce pharmaceutical prices.
Studies: Protectionism would mean fewer jobs
Two protectionist policies being considered by the White House would result in significant job losses, according to research released by the National Retail Federation.
The talk of the NACDS Annual Meeting
The National Association of Chain Drug Stores Annual Meeting last month in Palm Beach, Fla., unfolded against a backdrop of rapid-fire change in community pharmacy and the broader retailing and health care sectors.
The importance of regulatory compliance programs
In the current regulatory environment, it is imperative that a pharmacy maintain a robust regulatory compliance program in order to avoid the potentially significant legal and regulatory pitfalls.
Digital health consumers recasting the market
As of 2017, 45% of the global population was using the internet, and it is projected that 76% will have access by 2030, according to Euromonitor International. With more connectivity, a new type of connected consumer is rising: the digital health consumer.
Understanding Amazon’s impact on drug retailing
Who knew that the ancient Greek philosopher Heraclitus would sum up Amazon.com’s influence on our modern health care industry so well? “The only constant is change,” he is said to have uttered, along with “You cannot step twice into the same river.
It’s time to respect the differences of the ‘Big Three’
There are some consumers who see the drug store shopping experience as all about convenience.